ZYIL1: Clinical Trials

4 completed. 2 Phase 1, 2 Phase 2.

By phase and status

Phase	Trials	Status
Phase 1	2	Completed 2
Phase 2	2	Completed 2

Follow ZYIL1: new trials by email Literature Review of ZYIL1 trials Research Report on ZYIL1

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
Efficacy, Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ZYIL1 in Patients With Amyotrophic Lateral Sclerosis ZYIL1 capsules 25 mg and 50 mg Placebo, ZYIL1 capsules 50 mg and 25 mg Placebo, ZYIL1 capsules 25 mg and ZYIL1 capsules 50 mg - Amyotrophic Lateral Sclerosis	Phase 2	Completed	Zydus Lifesciences Limited	24	2023-11-09	2024-12-19
A Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ZYIL1 in Subjects With Cryopyrin Associated Periodic Syndromes (CAPS) ZYIL1 capsule - Cryopyrin Associated Periodic Syndrome	Phase 2	Completed	Zydus Lifesciences Limited	3	2022-06-01	2022-07-11
A Clinical Study to Evaluate the Safety, Tolerability and Pharmacokinetics and Pharmacodynamics of ZYIL1 Following Oral Administration in Healthy Volunteers ZYIL1 Capsule - Healthy	Phase 1	Completed	Zydus Lifesciences Limited	18	2021-07-12	2021-11-16
Clinical Study to Evaluate the Safety, Tolerability and Pharmacokinetics and Pharmacodynamics of ZYIL1 Following Oral Administration in Healthy Volunteers ZYIL1 capsule - Healthy	Phase 1	Completed	Zydus Lifesciences Limited	30	2020-12-28	2021-06-18

Conditions studied

Amyotrophic Lateral Sclerosis (1)  ·  COVID-19 (1)  ·  Cryopyrin-Associated Periodic Syndromes (1)

Sponsors

Zydus Lifesciences Limited (4)

Countries

India (3)  ·  Australia (1)

Top investigators

Dr Deven Parmar, MD (3)  ·  Dr. Deven Parmar, MD,FCP (1)

Results publications

PMID 36065092, PMID 40511876